Les Laboratoires Servier SAS Strategic SWOT Analysis Review
Number of Pages: 45
Published Date: 03 Nov 2021
Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Les Laboratoires Servier SAS (Servier) researches, develops, manufactures and markets drugs for treating various diseases. The companys portfolio of marketed products treats central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, hematological disorders, hormonal disorders and others. It invests substantial amount of revenue in R&D. Servier operates research centers in France and Hungary; and International Centers for Therapeutic Research (ICTRs). The company also provides generic drugs and contract development and manufacturing services across its global network. It sells products in Europe, America, Middle East, Africa, and Asia. Servier headquartered in Suresnes, France.
Les Laboratoires Servier SAS Key Recent Developments
Sep 20,2021: European Sustainable Development Week: Servier’s Ambitions are high
Sep 02,2021: Parkinson: a Collaboration for the Benefit of Therapeutic Acceleration
Aug 27,2021: Servier, 2nd Sponsor of the ESC 2021 Congress
Jul 01,2021: Oracle to integrate clinical trial operations of Servier
Jun 30,2021: Servier selects Oracle to unify its clinical trial operations
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Section 1 - About the Company
Les Laboratoires Servier SAS - Key Facts
Les Laboratoires Servier SAS - Key Employees
Les Laboratoires Servier SAS - Key Employee Biographies
Les Laboratoires Servier SAS - Major Products and Services
Les Laboratoires Servier SAS - History
Les Laboratoires Servier SAS - Company Statement
Les Laboratoires Servier SAS - Locations And Subsidiaries
Other Locations & Subsidiaries
Section 2 – Company Analysis
Les Laboratoires Servier SAS - Business Description
Product Category: Branded Medicines
Product Category: Generic Medicines
Geographical Segment: Africa and Middle East
Geographical Segment: Americas
Geographical Segment: Asia and Oceania
Geographical Segment: Europe (Outside the EU)
Geographical Segment: European Union
Les Laboratoires Servier SAS - SWOT Analysis
SWOT Analysis - Overview
Les Laboratoires Servier SAS - Strengths
Les Laboratoires Servier SAS - Weaknesses
Les Laboratoires Servier SAS - Opportunities
Les Laboratoires Servier SAS - Threats
Les Laboratoires Servier SAS - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Les Laboratoires Servier SAS, Recent Deals Summary
Section 4 – Company’s Recent Developments
Sep 20, 2021: European Sustainable Development Week: Servier’s Ambitions are high
Sep 02, 2021: Parkinson: a Collaboration for the Benefit of Therapeutic Acceleration
Aug 27, 2021: Servier, 2nd Sponsor of the ESC 2021 Congress
Jul 01, 2021: Oracle to integrate clinical trial operations of Servier
Jun 30, 2021: Servier selects Oracle to unify its clinical trial operations
Jun 23, 2021: Servier partners with BioLabs Global to open an incubator in Paris-Saclay for early stage life science companies
Jun 16, 2021: Olivier Laureau confirmed as second vice president of EFPIA
Jun 10, 2021: Vernalis and Servier achieve two milestones in their oncology drug discovery collaboration
Jun 09, 2021: World Anti-Counterfeiting Day: Servier on the front line for patient safety
Jun 02, 2021: Sardona Therapeutics, winner of the Servier spark award
Section 5 – Appendix